| Proportion of patients with the respective treatment modality (%) | ||||
---|---|---|---|---|---|
Number of patients | No treatment | Pharmacotherapy only | Psychotherapy only | Multimodal treatment | |
Overall | 91,118 | 50.2 | 36.5 | 6.8 | 6.5 |
Sex | |||||
 Male | 67,194 | 47.7 | 39.6 | 6.1 | 6.6 |
 Female | 23,924 | 57.2 | 28.0 | 8.9 | 5.9 |
Age group in years | |||||
 3–6 | 7498 | 89.1 | 4.6 | 5.2 | 1.1 |
 7–9 | 22,298 | 61.0 | 25.6 | 7.6 | 5.7 |
 10–12 | 26,139 | 44.7 | 39.9 | 7.6 | 7.8 |
 13–17 | 35,183 | 39.0 | 47.7 | 6.2 | 7.1 |
Selected psychiatric comorbidities | |||||
 Depressive disorders (F32, F33, F41.2, F43.2) | 11,651 | 36.2 | 31.9 | 18.0 | 14.0 |
 Tic disorders (F95) | 3030 | 41.2 | 40.6 | 8.0 | 10.2 |
 Pervasive developmental disorders (F84.0, F84.1, F84.5, F84.8, F84.9) | 5107 | 42.3 | 43.6 | 5.9 | 8.3 |
 Conduct disorders (F90.1, F91, F92) | 25,804 | 34.3 | 44.3 | 9.3 | 12.2 |
 Phobic anxiety disorders (F40, F41.0, F41.1, F41.3, F41.8, F41.9, F93) | 17,194 | 39.3 | 33.3 | 15.1 | 12.3 |
Number of psychiatric comorbiditiesa | |||||
 0 | 22,933 | 56.8 | 38.4 | 2.5 | 2.2 |
 1 | 26,200 | 52.1 | 36.7 | 5.9 | 5.3 |
 2 | 19,700 | 48.3 | 35.8 | 8.1 | 7.8 |
  ≥ 3 | 22,285 | 42.7 | 35.0 | 11.2 | 11.1 |